PCM Encore’s Johnson & Johnson JNJ Stock Holding History

PCM Encore’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Buy	7,539 +53	+0.7%	+$12.4K	0.34%	52
2026 Q1	$1.83M	Buy	7,486 +1,012	+16%	+$236K	0.38%	48
2025 Q4	$1.34M	Buy	+6,474	New	+$1.28M	0.29%	67

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PCM Encore's JNJ Position: Q2 2026 in Review

PCM Encore increased its Johnson & Johnson (JNJ) stake by 0.71% in Q2 2026, buying an estimated $12.4K and bringing the position to 7,539 shares worth $1.91M. The position accounts for 0.34% of the portfolio, ranked #52.

PCM Encore first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

PCM Encore held 7,539 shares of Johnson & Johnson worth $1.91M as of Q2 2026.
PCM Encore bought 53 Johnson & Johnson shares in Q2 2026, an estimated $12.4K.
Johnson & Johnson made up 0.34% of PCM Encore's portfolio in Q2 2026, its #52 holding.
PCM Encore first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.